NEW YORK, Jan. 21 (GenomeWeb News) - Inproteo, formerly known as the Indiana Proteomics Consortium, announced today that it has licensed US Patent No. 4,569,794 to Genentech.
The deal covers a patent, and its foreign counterparts, that describes a fusion protein purification technique known commonly as "His Tag."
The license covers all uses of the technology for the life of the patents, Inproteo said in a statement. Financial details were not disclosed.